EP3601239
NÝJAR HETERÓSÝKLÍSKAR AFLEIÐUR SEM ERU GAGNLEGAR SEM SHP2 HEMLAR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.3.2018EP published:
31.7.2024EP application number:
18770877.1
EP translation filed:
13.9.2024Grant published:
15.10.2024EPO information:
European Patent Register
Max expiry date:
22.3.2038Expiry date:
22.3.2027Next due date:
31.3.2027
Title in English:
NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORSLanguage of the patent:
English
Timeline
Today
23.3.2018EP application
31.7.2024EP Publication
13.9.2024Translation submitted
15.10.2024Registration published
22.3.2027Expires
Owner
Name:
Jacobio Pharmaceuticals Co., Ltd.Address:
Unit 2, Building 5, BYBP No.88 Kechuang Street 6th Business Development Area Daxing, Beijing 101111, CN
Inventor
Name:
MA, CunboAddress:
Beijing 101111, CN
Name:
GAO, PanliangAddress:
Beijing 101111, CN
Name:
HU, ShaojingAddress:
Beijing 101111, CN
Name:
XU, ZilongAddress:
Beijing 101111, CN
Name:
HAN, HuifengAddress:
Beijing 101111, CN
Name:
WU, XinpingAddress:
Beijing 101111, CN
Name:
KANG, DiAddress:
Beijing 101111, CN
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
PCT/IB2017/051690Date:
23.3.2017Country:
WO
Classification
Categories:
C07D 401/14, C07D 491/107, C07D 495/10, C07D 471/20, A61K 31/497, A61P 35/00, C07D 405/14, C07D 491/113, C07D 491/20, C07D 513/10, C07F 9/6558, C07D 471/10
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 18.3.2025
Expires: 22.3.2026
Payer: Árnason Faktor ehf.
Number: 9
Paid: 27.3.2026
Expires: 22.3.2027
Payer: Árnason Faktor ehf.